ALPN - Alpine Immune Sciences GAAP EPS of -$0.25 revenue of $13.63M
Alpine Immune Sciences press release (NASDAQ:ALPN): Q1 GAAP EPS of -$0.25. Collaboration Revenue of $13.63M. As of March 31, 2022, the company had cash, cash equivalents, and investments totaling $219.1 million. Net cash provided by operating activities for the quarter ended March 31, 2022 was $5.4 million compared to net cash used in operating activities of $16.0 million for the quarter ended March 31, 2021.
For further details see:
Alpine Immune Sciences GAAP EPS of -$0.25, revenue of $13.63M